In vitro antigiardial activity of IRE-6A and IRE-7B, two ethyl-phenylcarbamate derivatives

Revista de Investigacion Clinica

Volumn 55, Issue 4, 2003, Pages 444-447

  Jiménez Cardoso, Enedina ^a   Flores Luna, Andrés ^a   Angeles, E ^b   Martinez P ^b   Lopez Castanares R ^c   Castaneda Hernandez G ^d   Pérez Urizar, José ^e  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

^e UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Antiparasitic agents; Giardiasis; Phenylcarbamates

Indexed keywords

ALBENDAZOLE; ANTIPROTOZOAL AGENT; BENZIMIDAZOLE; CARBAMIC ACID DERIVATIVE; ETHYLPHENYLCARBAMATE DERIVATIVE; IRE 6A; IRE 7B; MACROLIDE; NITROFURAN; NITROIMIDAZOLE; OXIBENDAZOLE; PRAZIQUANTEL; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; FUNGAL STRAIN; GIARDIA LAMBLIA; GIARDIASIS; IN VITRO STUDY; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ALBENDAZOLE; ANIMALS; ANTIPROTOZOAL AGENTS; CARBAMATES; GIARDIA LAMBLIA;

EID: 0344898450     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Guerrant RL, Hughes JM, Lima NL, Crane J. Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis 1990; 12(Suppl. 1): S41-50.
2. Lewis DJ, Freedman AR. Giardia lamblia as an intestinal pathogen. Dig Dis 1992; 10(2): 102-11.
3. Farthing MJ. The molecular pathogenesis of giardiasis. J Pediatr Gastroenterol Nutr 1997; 24(1): 79-88.
4. Hall A, Nahar Q. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans R Soc Trop Med Hyg 1993; 87(1): 84-6.
5. Rosenblatt JE. Antiparasitic agents. Mayo Clin Proc 1999; 74(11): 1161-75.
6. Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA. Treatment of patients with refractory giardiasis. Clin Infect Dis 2001; 33(1): 22-8.
7. Upcroft P, Upcroft JA. Drug targets and mechanism of resistance in the anaerobic protozoa. Clin Microbiol Rev 2001; 14(1): 150-64.
8. Goto R, Panter-Brick C, Northrop-Clewes CA, Manahdhar R, Tuladhar NR. Poor intestinal permeability in mildly stunted Nepali children: associations with weaning practices and Giardia lamblia infection. Br J Nutr 2002; 88(2): 141-9.
9. Moya-Camarena SY, Sotelo N, Valencia ME. Effects of asymptomatic Giardia intestinalis infection on carbohydrate absorption in well-nourished Mexican children. Am J Trop Med Hyg 2002; 66(3): 255-9.
10. Morgan UM, Reynoldson JA, Thompson RC. Activities of several benzimidazoles and tubulin inhibitors against Giardia ssp in vitro. Antimicrob Agents Chemother 1993; 37(2): 328-31.
11. Lemee V, Zaharia I, Nevez G, Rabodonirina M, Brasseur P, Ballet JJ, Favennec L. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. J Antimicrob Chemother 2000; 46(5): 819-21.
12. Hollomon DW, Butters JA, Baker H. Tubulins: a target for antifungal agents. In: Bentley PH, O'Hanlon PJ. Anti-infectives: recent advances in chemistry and structure activity relationship. London, UK: Royal Society of Chemistry. 1997:152-6.
13. Kato T, Suzuki K, Takahashi J, Kamoshita K. Negatively correlated cross-resistance between benzimidazole fungicides and methyl-(3,5-dichloraphenyl) carbamate. Noyaku Gakkaishi (J Pestic Sci) 1984; 9: 489-95.
14. Vanelle P, Maldonado J, Gasquet M, Delmas F, Timon-David P, Jentzer O, Crozet MP. Studies on antiparasitic agents: effect of the lactam nucleus substitution in the 2-position on the in-vitro activity of new 5-nitroimidazoles. J Pharm Pharmacol 1991; 43(10): 735-6.
15. Angeles E, Jiménez-Cardoso E, Flores-Luna A, Moreno E, Arroyo V, Martínez P, Martínez R, López R. Ethyl and methylphenylcarbamates as antihelmintic agents; theoretical study for predicting their biological activity by pm3. J Mol Struct (Teochem) 2000; 504: 141-70.
16. Angeles E, Santillan A, Martínez I, Ramírez A, Solomon M, Martínez R, Moreno E. A simple method for the synthesis of carbamates. Synt Comm 1994; 24: 2441-7.
17. Upcroft JA, Upcroft P. Drug susceptibility testing of anaerobic protozoa. Antimicrob Agents Chemother 2001; 45(6): 1810-4.
18. Keister DB. Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans R Soc Trop Med Hyg 1983; 77(4): 487-8.
19. el Sayad MH. Lofty WM, el-Kholy SM, Yehia MA. Efficacy of praziquantel against Giardia lamblia in rats: parasitological, pathological and therapeutic study. J Egypt Soc Parasitol 2002; 32(1): 201-18.
20. Cedillo-Rivera R, Muñoz O. In vitro susceptibility of Giardia intestinalis to albendazole, mebendazole and other chemotherapeutic agents. J Med Microbiol 1992; 37(3): 221-4.
21. Katelaris PH, Naeem A, Farthing MJ. Activity of metronidazole azithromycin and three benzimidazoles on Giardia lamblia growth and attachment to a human intestinal cell line. Aliment Pharmacol Ther 1994; 8(2): 187-92.
22. Abboud P, Lemee V, Gargala G, Brasseur P, Ballet JJ, Borsa-Lehas F, Caron F, Favvenec L. Successful treatment of metronidazole-and-albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 2001; 32(12): 1792-4.
23. Rizzotelli G, Scarabelli G, Velardi S. Albendazole a new therapeutic regimen in cutaneous Larva migrans. Int. J Dermatol 1997; 36(9): 700-3.
24. Marti H, Haji HJ, Savioli L, Chwaya HM, Mgeni AF, Ameir JS, Hatz CA. Comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helmintic infections in children. Am J Trop Med Hyg 1996; 55(5): 477-81.
25. Upcroft JA, Campbell RW, Upcroft P. Quinacrine-resistant Giardia duodenalis. Parasitology 1996; 112: 309-3.
26. Lindquist HD. Induction of albendazole resistance in Giardia lamblia. Microb Drug Resist 1996; 2(4): 433-4.
27. Kohler P. The biochemical basic of antihelmintic action and resistance. Int J Parasitol 2001; 31(4): 336-45.
28. Samuelson J. Why metronidazole is active against both bacteria and parasites. Antimicrob Agents Chemother 1999; 43(7): 1533-41.
29. Hollomon DW, Butters JA, Barker H, Hall L. Fungal beta-tubulin expressed as a fusion protein, binds benzimidazole and phenylcarbamate fungicides. Antimicrob Agents Chemother 1998; 42(9): 2117-3.